Curative Biotechnology Inc Business Finance Contracts & Agreements
74 Contracts & Agreements
- Note Agreements (25 contracts)
- Purchase Agreements (5)
- Security Agreements (6)
- Stock Agreements (10)
- Subscription Agreements (4)
- Underwriting Agreements (1)
- Warrant Agreements (23)
- Seventeenth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on May 6, 2024)
- Sixteenth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on May 6, 2024)
- Fifteenth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on May 6, 2024)
- Fourteenth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on May 6, 2024)
- Thirteenth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on May 6, 2024)
- Twelfth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on May 6, 2024)
- Eleventh Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on May 6, 2024)
- Tenth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on May 6, 2024)
- Ninth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on May 6, 2024)
- Eighth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on May 6, 2024)
- Seventh Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on January 25, 2023)
- Seventh Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on January 13, 2023)
- Sixth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on January 9, 2023)
- Fifth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on November 30, 2022)
- Fourth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on November 30, 2022)
- Third Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on November 30, 2022)
- Second Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on November 30, 2022)
- Form of Warrant Agency Agreement (Filed With SEC on November 7, 2022)
- Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on November 7, 2022)
- Warrant for March 2022 Offering (Filed With SEC on November 7, 2022)
- Intellectual Property Security Agreement for March 2022 Offering (Filed With SEC on November 7, 2022)
- Security Agreement for March 2022 Offering (Filed With SEC on November 7, 2022)
- Secured Convertible Promissory Note for March 2022 Offering (Filed With SEC on November 7, 2022)
- Securities Purchase Agreement for March 2022 Offering (Filed With SEC on November 7, 2022)
- Exclusive Option Agreement for Purchase of Patent Rights dated September 30, 2020 between Curative Biotechnology (fka Connectyx Technologies Holdings Group) and IEM Inc (Filed With SEC on November 7, 2022)
- Form of Note Issued to Investors between November 2020 and January 2021 (Filed With SEC on November 7, 2022)
- Form of Subscription Agreement for Investor Offerings on May 21, 2021 (Filed With SEC on November 7, 2022)
- Form of Subscription Agreement for Investor Offerings in August 2021 (Filed With SEC on November 7, 2022)
- Form of warrant to be issued in Underwritten Offering (Filed With SEC on November 7, 2022)
- Form of Underwriter Warrant (Filed With SEC on November 7, 2022)
- Form of Common Stock Purchase Option issued to Catherine Sohn pursuant to Consulting Agreement dated September 27, 2021 (Filed With SEC on November 7, 2022)
- Form of Common Stock Purchase Warrant issued to Marc Drimer on July 14, 2021 (Filed With SEC on November 7, 2022)
- Form of Common Stock Purchase Warrant issued to Paul Michaels on June 11, 2021 (Filed With SEC on November 7, 2022)
- Form of Common Stock Purchase warrant issued to Consultant on December 3, 2020 (Filed With SEC on November 7, 2022)
- Form of Warrant issued to Investors in Note Offering from November 2020 through January 2021 (Filed With SEC on November 7, 2022)
- Form of Warrant issued to investors on May 21, 2021 (Filed With SEC on November 7, 2022)
- Form of Common Stock Purchase Warrant issued to Investors in August 2021 (Filed With SEC on November 7, 2022)
- Form of Common Stock Purchase Warrant issued to Certain Consultants in May 2021 (Filed With SEC on November 7, 2022)
- Specimen of Series C Preferred Stock (Filed With SEC on November 7, 2022)
- Specimen of Series B Preferred Stock (Filed With SEC on November 7, 2022)
